177 related articles for article (PubMed ID: 38596681)
21. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?
Steck AK; Zhang W; Bugawan TL; Barriga KJ; Blair A; Erlich HA; Eisenbarth GS; Norris JM; Rewers MJ
Diabetes; 2009 Apr; 58(4):1028-33. PubMed ID: 19188433
[TBL] [Abstract][Full Text] [Related]
22. LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells.
Kim NS; Torrez T; Langridge W
Cell Immunol; 2019 Apr; 338():32-42. PubMed ID: 30910218
[TBL] [Abstract][Full Text] [Related]
23. Insulin's other life: an autoantigen in type 1 diabetes.
Mannering SI; Bhattacharjee P
Immunol Cell Biol; 2021 May; 99(5):448-460. PubMed ID: 33524197
[TBL] [Abstract][Full Text] [Related]
24. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.
Walter M; Albert E; Conrad M; Keller E; Hummel M; Ferber K; Barratt BJ; Todd JA; Ziegler AG; Bonifacio E
Diabetologia; 2003 May; 46(5):712-20. PubMed ID: 12750767
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma.
Zwicker K; Chatten C; Gratton K; Demetrick D; Serra P; Shameli A; Santamaria P; Bathe OF
J Immunol; 2009 Aug; 183(3):1705-14. PubMed ID: 19570832
[TBL] [Abstract][Full Text] [Related]
26. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.
van Lummel M; Duinkerken G; van Veelen PA; de Ru A; Cordfunke R; Zaldumbide A; Gomez-Touriño I; Arif S; Peakman M; Drijfhout JW; Roep BO
Diabetes; 2014 Jan; 63(1):237-47. PubMed ID: 24089515
[TBL] [Abstract][Full Text] [Related]
27. T cell reactivity to human insulinoma cell line (CM) antigens in patients with type 1 diabetes.
Monetini L; Cavallo MG; Barone F; Valente L; Russo M; Walker B; Thorpe R; Pozzilli P
Autoimmunity; 1999; 29(3):171-7. PubMed ID: 10433097
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic basis of immunotherapies for type 1 diabetes mellitus.
Chen W; Xie A; Chan L
Transl Res; 2013 Apr; 161(4):217-29. PubMed ID: 23348026
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation near the INS gene is associated with INS genetic variation (rs689) and type 1 diabetes in the Diabetes Autoimmunity Study in the Young.
Carry PM; Vanderlinden LA; Johnson RK; Dong F; Steck AK; Frohnert BI; Rewers M; Yang IV; Kechris K; Norris JM
Pediatr Diabetes; 2020 Jun; 21(4):597-605. PubMed ID: 32061050
[TBL] [Abstract][Full Text] [Related]
30. Deleting islet autoimmunity.
Liu E; Li M; Jasinski J; Kobayashi M; Gianani R; Nakayama M; Eisenbarth GS
Cell Biochem Biophys; 2007; 48(2-3):177-82. PubMed ID: 17709887
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
32. HLA-DR-restricted T cell lines from newly diagnosed type 1 diabetic patients specific for insulinoma and normal islet beta cell proteins: lack of reactivity to glutamic acid decarboxylase.
Huang GC; Tremble J; Bailyes E; Arden SD; Kaye T; McGregor AM; Banga JP
Clin Exp Immunol; 1995 Oct; 102(1):152-8. PubMed ID: 7554382
[TBL] [Abstract][Full Text] [Related]
33. miRNA-Mediated Immune Regulation in Islet Autoimmunity and Type 1 Diabetes.
Scherm MG; Daniel C
Front Endocrinol (Lausanne); 2020; 11():606322. PubMed ID: 33329406
[TBL] [Abstract][Full Text] [Related]
34. Type 1 diabetes induction in humanized mice.
Tan S; Li Y; Xia J; Jin CH; Hu Z; Duinkerken G; Li Y; Khosravi Maharlooei M; Chavez E; Nauman G; Danzl N; Nakayama M; Roep BO; Sykes M; Yang YG
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10954-10959. PubMed ID: 28874533
[TBL] [Abstract][Full Text] [Related]
35. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms in autoimmune type 1 diabetes: a critical review.
Xie Z; Chang C; Zhou Z
Clin Rev Allergy Immunol; 2014 Oct; 47(2):174-92. PubMed ID: 24752371
[TBL] [Abstract][Full Text] [Related]
37. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
38. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.
Lempainen J; Härkönen T; Laine A; Knip M; Ilonen J;
Pediatr Diabetes; 2013 Nov; 14(7):490-6. PubMed ID: 23721563
[TBL] [Abstract][Full Text] [Related]
39. Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial.
Assfalg R; Knoop J; Hoffman KL; Pfirrmann M; Zapardiel-Gonzalo JM; Hofelich A; Eugster A; Weigelt M; Matzke C; Reinhardt J; Fuchs Y; Bunk M; Weiss A; Hippich M; Halfter K; Hauck SM; Hasford J; Petrosino JF; Achenbach P; Bonifacio E; Ziegler AG
Diabetologia; 2021 May; 64(5):1079-1092. PubMed ID: 33515070
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
Nossal GJ; Herold KC; Goodnow CC
Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
